VRDN
Viridian Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -14.1% ·
share flow +7.2% ·
net new positions -16.4%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | -12 | 71.65M | $1.32B | +6 | −18 |
| Q1 2026 | 88 | +7 | 66.96M | $1.32B | +11 | −5 |
| Q4 2025 | 82 | +2 | 62.58M | $1.95B | +4 | −1 |
| Q3 2025 | 16 | -1 | 34.97M | $754.70M | — | −1 |
| Q2 2025 | 14 | -2 | 33.44M | $467.46M | — | −2 |
| Q1 2025 | 13 | +2 | 10.47M | $141.20M | +2 | — |
| Q4 2024 | 11 | -2 | 10.88M | $208.63M | — | −2 |
| Q3 2024 | 12 | +3 | 5.78M | $131.57M | +3 | — |
| Q2 2024 | 9 | — | 3.15M | $40.97M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 16.60M | +8.0% | $305.03M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 2 | State Street Global Advisors ✦ (passive) | 6.12M | +31.1% | $112.52M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 5.75M | +79.3% | $105.60M | 0.0% | ▲ Add | 9 | SEC ↗ ×2 |
| 4 | Dimensional Fund Advisors Lp | 1.61M | +204.2% | $29.61M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 5 | Bank Of America Corp /De/ | 944.35K | -18.8% | $17.35M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 6 | Northern Trust Corp | 863.49K | +23.9% | $15.86M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 7 | JPMorgan Chase ✦ | 639.93K | -39.6% | $12.11M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 8 | Wells Fargo & Company/Mn | 115.56K | +24.0% | $2.12M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 9 | Barclays Plc | 81.43K | -19.1% | $1.50M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 10 | Legal & General Group Plc | 64.79K | +8.7% | $1.19M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 11 | Sei Investments Co | 14.54K | -77.9% | $266,980 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 12 | Pnc Financial Services Group, Inc. | 222 | +7.2% | $4,078 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Fifth Third Bancorp | 208 | -32.0% | $3,814 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Us Bancorp \De\ | 190 | -93.5% | $3,490 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Loomis Sayles & Co L P | $18.15M | was 0.0% |
| Raymond James Financial Inc | $5.45M | was 0.0% |
| Jennison Associates Llc | $548,834 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 225 holders, 111.32M shares, $2.12B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 4.21K sh · $103,194
Officer · 10.00K sh · $245,000
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology